Through both in vitro and in vivo experiments, it was found that SNX10 regulated the PI3K/Akt signaling pathway, affecting B-ALL cell proliferation, apoptosis, cell cycle progression, and disease progression. This evidence concerns the gene SNX10 and precursor B-cell acute lymphoblastic leukemia.